A novel approach to determining tumor progression using a three-site pilot clinical trial of spectroscopic mri-guided radiation dose escalation in glioblastoma

HIGHLIGHTS

• who: Karthik K. Ramesh and colleagues from the Department of Oncology, Emory University School of Medicine, Atlanta, GA, USA have published the research: A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma, in the Journal: Tomography 2023, 9, of /2023/
• what: The aim of this study is to determine true tumor recurrence timepoints for patients in the dose -escalation multisite study using novel methodology and to report on median progression-free survival (PFS). The authors demonstrate how the authors determined progression . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.